EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Treatment plan quality comparison between ZAP‐Axon ® Krylov optimizer and Leksell Gamma Knife ® Lightning optimizer for brain metastasis

Yongsook C. Lee, Alexander Maslowski, Rupesh Kotecha, Ranjini Tolakanahalli, D Jay Wieczorek, Matthew D. Hall, Minesh P. Mehta, Michael W. McDermott, Alonso N. Gutierrez

Journal of Applied Clinical Medical Physics · 2026-11 · 27 (11)

DOI: 10.1002/acm2.70851 ↗
AbstractBibliografische Angaben

Abstract

Abstract Purpose This study compares stereotactic radiosurgery (SRS) treatment plan quality between the recently launched ZAP‐Axon ® Krylov optimizer and the Leksell Gamma Knife ® (LGK) Lightning optimizer for brain metastasis (BM). Methods Thirty ( n = 30) patients who were previously treated with LGK SRS or fractionated SRS were selected and divided into three groups: large post‐operative resection cavities of BM (BM lg, postop ), large intact BM (BM lg, intact ) and small intact BM (BM sm, intact ). Based on our institutional planning guidelines, the 30 clinical cases were replanned using ZAP‐Axon Krylov and LGK Lightning optimizers without manual adjustments. Statistical analysis was performed to compare plan quality metrics (Paddick conformity index [PCI], gradient index [GI], target coverage [TC], prescribed isodose line [Rx IDL], and treatment time/scaled beam‐on‐time [sBOT] [min]) between the two optimizers. Results For the BM lg, postop group, mean values of PCI, GI, TC, Rx IDL, and treatment time/sBOT (min) for Krylov versus Lightning plans were 0.91 versus 0.91, 2.48 versus 2.56, 99.5% versus 99.7%, 51.1% versus 53.7% and 37.4 min versus 36.5 min, respectively. All metrics except for the Rx IDL (%) were not statistically significantly different. For the BM lg, intact group, corresponding values were 0.93 versus 0.93, 2.42 versus 2.57, 99.5% versus 99.7%. 51.5% versus 53.0% and 35.9 min versus 36.3 min. While GI was statistically significantly different ( p

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →